The American College of Radiology criticized a study by the Agency for Healthcare Research and Quality that found current noninvasive imaging cannot replace biopsy to exclude or confirm breast cancer.
The American College of Radiology criticized a study by the Agency for Healthcare Research and Quality that found current noninvasive imaging cannot replace biopsy to exclude or confirm breast cancer.
The report, Effectiveness of noninvasive diagnostic tests for breast abnormalities, stated that the accuracy of scintimammography, PET, ultrasound, and MRI is suboptimal compared with biopsy.
Officials in the ACR said that breast imagers are well acquainted with the protocol regarding a suspicious mammographic finding, which generally calls for biopsy. The college also expressed concern that the report would mislead women into foregoing additional imaging after an inconclusive screening mammogram.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.